Masimo Corp Files 8-K on Financials

Ticker: MASI · Form: 8-K · Filed: Jan 16, 2025 · CIK: 937556

Masimo CORP 8-K Filing Summary
FieldDetail
CompanyMasimo CORP (MASI)
Form Type8-K
Filed DateJan 16, 2025
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: MASI

TL;DR

MASI filed an 8-K, check financials and exhibits.

AI Summary

Masimo Corporation filed an 8-K on January 16, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Irvine, California.

Why It Matters

This filing provides investors with crucial updates on Masimo's financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine filing of financial information and does not indicate any immediate operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Masimo Corporation?

The primary purpose is to report on Masimo Corporation's results of operations and financial condition, as well as to include Regulation FD disclosures and financial statements and exhibits.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on January 16, 2025.

In which state is Masimo Corporation incorporated?

Masimo Corporation is incorporated in Delaware (DE).

What is the address of Masimo Corporation's principal executive offices?

The address of Masimo Corporation's principal executive offices is 52 Discovery, Irvine, CA 92618.

What is the SIC code for Masimo Corporation?

The Standard Industrial Classification (SIC) code for Masimo Corporation is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.

Filing Stats: 817 words · 3 min read · ~3 pages · Grade level 12.4 · Accepted 2025-01-16 08:01:57

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 16, 2025, Masimo Corporation (the "Company") issued a press release announcing select preliminary financial results for the fourth quarter and full-year ended December 28, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report. The preliminary financial information presented in this press release is based on the Company's current expectations and may be adjusted as a result of, among other things, completion of customary annual audit procedures. The Company's management plans to discuss the Company's complete fourth quarter and full-year 2024 financial results after the market closes on Tuesday, February 25, 2025. In accordance with General Instructions B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. In connection with the Company's participation at the 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025, the Company's Interim Chief Executive Officer and EVP, Chief Financial Officer, will review select preliminary financial results for the fourth quarter and full-year 2024 and estimates for its full-year 2025 financial guidance. In addition, the Company is making available to investors supplemental financial information for fiscal 2017, 2018, 2019, 2020, 2021, 2022, 2023 and the first, second and third quarter of fiscal 2024 pursuant to the materials furnished as Exhibit 99.2 to this Current Report, as well as a discussion of non-GAAP measures, adjustments and definitions pursuant to the materials furnished as Exhibit 99.3 to this Current Report. In accordance with General Instructions B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) The following items are filed as exhibits to the Current Report on Form 8-K. Exhibit No. Description 99.1 Press Release, Dated January 16, 2025, Reporting Select Preliminary 2024 Financial Results and 2025 Guidance 99.2 Masimo Fourth Quarter 2024 Preliminary Supplemental Earnings Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Masimo Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MASIMO CORPORATION Date: January 16, 2025 By: /s/ M ICAH Y OUNG Micah Young Executive Vice President & Chief Financial Officer (Principal Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing